A Pilot Trial Examining the Merits of Combining Amantadine and Repetitive Transcranial Magnetic Stimulation as an Intervention for Persons With Disordered Consciousness After TBI
Enregistré dans:
Auteurs principaux: | Sandra Kletzel, Theresa Bender Pape, Amy Herrold, Sherri Livengood, Ann Guernon, Todd Parrish, Trudy Mallinson, james higgins, Joshua Rosenow, Dulal Bhaumik |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3f2dbe09e634bd38a609980b49ed29f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
par: Amy Herrold, et autres
Publié: (2021) -
Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
par: Theresa Bender Pape
Publié: (2021) -
Clinical and genetic investigation of amantadine-associated corneal edema
par: Hessen MM, et autres
Publié: (2018) -
Precision targeting of brain networks in TBI
par: Shan Siddiqi
Publié: (2021) -
Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells
par: Po-Yen Lee, et autres
Publié: (2021)